Back to Research Home
PHGKoninklijke Philips NV ADR
Health Care · Medical Electronics
$26.89−0.11%
As of 23 Oct 2026Mkt cap —
Stage 13
WAIT
Fundamentals
—/75
Technical
10.6/15
Independent
—/90
GCAE viewFundamental evidence is unavailable, so the engine cannot approve ownership
Price
- 1M
- +9.5%
- 3M
- +7.5%
- 6M
- +1.5%
- 1Y
- −2.4%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- —
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- —
- FCF yield
- —
Quality
- ROIC
- 6.6%
- Operating margin
- 2.9%
- FCF margin
- —
- Current ratio
- 1.3x
Growth
- Revenue growth
- +3.3%Latest FY YoY
- Revenue CAGR
- −0.2%
- EPS CAGR
- −29.0%
- FCF CAGR
- —
Capital
- Share-count trend
- +0.7%3Y annualised
- Net debt
- $6.2B
Annual trend
- CAGR 2021–2025
- −0.2%
- Latest · 2025
- $20B
- YoY
- +3.3%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental evidence is unavailable, so the engine cannot approve ownership
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-03
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- early-recovery
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded